EXTON, Pa., May 23 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the FBR 12th Annual Spring Investor Conference at the Grand Hyatt New York Hotel in New York City on Wednesday, May 28, 2008.
Douglas G. Evans, Kensey Nash's COO, will deliver the Company's presentation, beginning at approximately 12:50 p.m. (EDT). To hear the live webcast of the Kensey Nash presentation at the FBR conference, go to http://www.wsw.com/webcast/fbr21/knsy/ and access the conference link. The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 12:50 p.m. (EDT) on Wednesday, May 28, 2008.
About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also developed and commercialized a series of innovative endovascular products and recently announced the sale of this product line to Spectranetics, Inc. In conjunction with the sale transaction, the Company will continue to manufacture and develop these products for Spectranetics for a period of time. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
'/>"/>
| SOURCE Kensey Nash Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Corrected Press Release: Kensey Nash to Present at the Bank of America 2008 Health Care Conference
2. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
3. Kensey Nash Reports Third Quarter Record Revenue and Sales
4. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
6. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
7. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
8. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
9. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
10. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
11. Kensey Nash Announces $25 Million Stock Repurchase Program
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |